News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024
News Conference News TCT 2024 Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI Michael O'Riordan November 06, 2024
News Conference News NY Valves 2024 Risk Score IDs Patients Safe for Same-Day Discharge After Low-Risk TAVI Michael O'Riordan June 06, 2024
News Conference News EuroPCR 2024 Temporary Pacemaker After TAVI May Preclude Long-term Pacing Caitlin E. Cox May 24, 2024
News Conference News TCT 2023 Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots Caitlin E. Cox November 03, 2023
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
News Conference News EHRA 2023 EPs Push for More Involvement in TAVI Heart Team Discussions Michael O'Riordan April 21, 2023
News Conference News AHA 2022 Partial Oral Antibiotic Regimen for Endocarditis Effective in Real World Michael O'Riordan November 10, 2022
News Conference News AHA 2021 PALACS: Posterior Left Pericardiotomy Cuts Postop AF After Cardiac Surgery Todd Neale November 14, 2021
News Conference News CRT 2021 DOAC Use Increasing in Patients With Bioprosthetic Heart Valves Todd Neale March 08, 2021
News Conference News EuroPCR 2019 Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats Michael O'Riordan May 22, 2019
News Conference News STS 2019 Past SAVR Outcomes Matter More Than Volume in Determining Future Performance Yael L. Maxwell January 31, 2019
News Conference News ISET 2017 Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients Caitlin E. Cox February 06, 2017